AI interpretation based on checked source excerpts. Issuer assertions and evidence limitations remain explicit.
Policy quality-scores-2: six equally weighted categories. The overall score requires full coverage. Missing inputs are not zero. Qualitative grades are sourced interpretations, not probabilities. 2/6 · 18/10/2026
Moat—
Insufficient evidence for every rubric criterion; no category score is inferred.
structural advantage · — · Technology sharing, IP reliance and new-product sales demonstrate capabilities, but their competitive exclusivity is unresolved.
durability · — · Repeated disclosure of the technology model establishes continuity, not durable protection of economic returns.
customer dependency · — · Approval constraints concern particular third-party components; the passages cannot establish customer dependency on 3M.
erosion resilience · — · Industrial growth and productivity coexist with Consumer weakness and realized cost pressures. Resilience of a structural advantage remains unestablished.
Pricing power—
Insufficient evidence for every rubric criterion; no category score is inferred.
realized pricing · 2/4 · Historical disclosures attribute partial offsets to pricing actions, demonstrating some realized benefit. The passages do not isolate price realization, demand response or persistence, and recent production cost pressure remains material.
retention · 2/4 · Indirect operating evidence is mixed: first-half 2026 industrial segment sales increased while Consumer sales declined. Customer approvals indicate some transition friction, but neither repeat-customer retention rates nor price-related attrition are disclosed.
margin resilience · 2/4 · Industrial segment operating income increased, while Consumer operating income declined and company cost of sales rose from 57.9% to 59.0% of first-half sales. Productivity partly offset realized cost headwinds; this is mixed resilience and does not independently prove pricing power.
contractual freedom · — · No supplied customer contract terms establish price-reset rights, escalation clauses, termination rights or restrictions on changing commercial terms.
Predictability74
Five consecutive annual periods. Equal weights: nondeclining revenue frequency; revenue-growth volatility (5–40pp); positive FCF frequency; FCF-margin volatility (3–20pp). Stability indicator, not a growth forecast.
- Nondeclining revenue years (%)
- 25.00
- Revenue growth volatility (pp)
- 10.10
- Positive FCF years (%)
- 100.00
- FCF margin volatility (pp)
- 5.45
Financial strength—
Missing required inputs: netDebtEbitGrade. Equal-weight grades: debt/FCF (1–8x), net debt/earnings before interest and tax (0–5x), interest service (1–12x), current ratio (0.75–2x). Earnings use reported operating income, or reported pretax profit plus reported interest expense when operating income is unavailable. Interest service uses earnings/interest expense; if unavailable, it uses reported operating cash flow/cash interest paid, without relabeling cash paid as accrued expense. Nonpositive cash flow/earnings score 0 for their service component; reported zero interest with a positive numerator scores 100. Net cash scores 100 for net leverage. Missing disclosures remain unavailable. General nonfinancial-company rubric, not a credit rating; exceptional and nonoperating gains are not normalized out. IFRS finance-cost and cash-flow classifications retain their reported scope.
- debtFcfGrade
- 0.00
- interestCoverageGrade
- 35.39
- currentRatioGrade
- 76.63
- Debt / FCF (x)
- 9.03
- Interest coverage (x)
- 4.89
- Current ratio (x)
- 1.71
Capital allocation—
Missing required inputs: operatingReturn. Three-year equal-weight indicators: pretax return on average invested capital (0–25%; equity + debt − cash, each year and its prior year), share-count growth (0–5%, lower better), share-based cost/revenue (2–20%, lower better), consolidated FCF/net income (0–1x). Return uses reported operating income or, if unavailable, EBIT calculated from reported pretax profit plus reported interest expense; exceptional/nonoperating gains are not normalized out. Share-based cost uses the reported cash-flow add-back or, if absent, separately reported recognized compensation expense; the latter never becomes an FCF adjustment. Nonpositive net income scores 0 for cash conversion; absent income/FCF stays unavailable. Nonpositive invested capital has no defined return and remains unavailable. Does not establish acquisition quality or buyback timing.
- 3-year average dilution (%)
- -7.14
- 3-year average SBC / revenue (%)
- 0.97
- cashConversionGrade
- 0.00
Management56
Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.
capital discipline · 2/4 · First-half 2026 operating cash flow of $1.56 billion funded $448 million of PP&E spending, but $2.993 billion of repurchases and $813 million of dividends accompanied a substantial cash reduction. Actual 2025 debt repayments exceeded issuance. Investment and financing discipline are mixed; repurchase value creation is unproven.
incentive alignment · 2/4 · Actual 2025 awards included substantial performance shares with three-year EPS and free-cash-flow metrics, and executives cannot hedge or pledge shares. Tariff effects remained in payout calculations, but approved exclusions for litigation, transformation, divestitures and PFAS exit impacts weaken linkage to total shareholder costs. Actual ownership is missing.
execution · 2/4 · Commercialized innovation, industrial segment growth and completion of the PFAS manufacturing exit demonstrate execution. Consumer declines and realized exit-related cost dis-synergies qualify that progress. Assessment partly uses indirect segment operating evidence and issuer-reported achievements.
governance · 3/4 · Disclosed arrangements include independent committee safeguards, annual majority elections, a serving Lead Independent Director and adopted confidential complaint procedures. These support strong governance structures, while their long-term effectiveness and exceptional durability are not demonstrated.
Evidence
3M’s business segments bring together common or related 3M technologies, enhancing the development of innovative products and services and providing for efficient sharing of business resources.
Item 1, Business Segments: shared technologies and resources · Filed 03/02/2026
The Company also relies on patent and other intellectual property protection, and challenges to the Company’s intellectual property rights, or claims that the Company’s activities interfere with the intellectual property rights of a third party, could cause the Company to incur significant expenses to assert or defend against such claims, could result in reduced revenue, and could damage the Company’s reputation, any of which could have a material adverse effect on the Company.
Risk factors: reliance on intellectual property protection · Filed 05/02/2025
Our R&D investments led to 284 new product introductions (up 68% from 2024) and a double-digit increase in new product sales – indicating that innovation has made a strong resurgence at 3M.
Proxy shareholder letter: 2025 product introductions and new-product sales · Filed 25/03/2026
3M’s business segments bring together common or related 3M technologies, enhancing the development of innovative products and services and providing for efficient sharing of business resources.
Item 1, Business Segments: technology sharing in the prior annual report · Filed 05/02/2025
Most 3M products involve expertise in product development, manufacturing and marketing, and are subject to competition from products manufactured and sold by other technologically oriented companies.
Item 1, General: competition from technologically oriented companies · Filed 03/02/2026
Demand for the Company’s products, which impacts revenue and profit margins, is affected by, among other things: (i) the development and timing of the introduction of competitive products; (ii) the Company’s pricing strategies; (iii) changes in customer order patterns, such as changes in the levels of inventory maintained by customers, vendors, or channel partners; (iv) changes in customers’ preferences for our products, including preferences for products that do not contain third-party manufactured PFAS, the success of products offered by our competitors, and changes in customer designs for their products that can affect the demand for some of the Company’s products; and (v) changes in the business environment related to disruptive technologies, such as artificial intelligence and machine learning technologies, block-chain, expanded analytics, and other enhanced learnings from increasing volume of available data.
Risk factors: competitive products, pricing, customer designs and preferences · Filed 03/02/2026
Management believes that the confidence of these partners in 3M and its products — a confidence developed through long association with skilled marketing and sales representatives — has contributed significantly to 3M’s position in the marketplace and to its growth.
Item 1, Business: management's explanation of channel relationships · Filed 03/02/2026
Operating Expenses: Three months ended June 30, Six months ended June 30, (Percent of net sales) 2026 2025 Change 2026 2025 Change Cost of sales 58.7 % 57.5 % 1.2 % 59.0 % 57.9 % 1.1 % Selling, general and administrative expenses (SG&A) 16.4 19.9 (3.5) 14.4 18.0 (3.6) Research, development and related expenses (R&D) 4.6 4.5 0.1 4.9 4.7 0.2 Loss on business divestitures 5.2 0.1 5.1 2.7 — 2.7 Operating income margin 15.1 % 18.0 % (2.9) % 19.0 % 19.4 % (0.4) % Cost of Sales measured as a percent of sales: Increases in the second quarter and first six months of 2026 were primarily due to cost dis-synergies following the exit of PFAS manufacturing and headwinds from rising oil prices and tariff impacts, partially offset by ongoing manufacturing productivity initiatives.
MD&A, Operating Expenses: realized cost pressures and productivity offsets · Filed 21/07/2026
In certain cases, PFAS-containing third-party products (such as lithium ion batteries, printed circuit boards, certain seals and gaskets, and other products widely used in commerce across a variety of industries) continue to be used beyond the end of 2025 due to technological constraints, regulatory or industry standards, or the need for customer transitions, certifications, or approvals.
PFAS exit discussion: third-party components and customer approval constraints · Filed 21/07/2026
Transitional efforts related to products manufactured prior to the end of 2025 and customer conversion processes also remain ongoing.
PFAS exit discussion: ongoing customer conversions · Filed 21/07/2026
40 Table of Contents Business Segment Information Three months ended June 30, Six months ended June 30, Net sales (millions) 2026 2025 2026 2025 Safety and Industrial $ 3,091 $ 2,857 $ 6,021 $ 5,602 Transportation and Electronics 2,066 1,944 3,914 3,760 Consumer 1,247 1,270 2,378 2,394 Total reportable business segment net sales 6,404 6,071 12,313 11,756 Corporate 96 273 217 542 Total Company $ 6,500 $ 6,344 $ 12,530 $ 12,298 Significant segment expenses and operating performance (millions) Safety and Industrial Cost of sales $ 1,642 $ 1,537 $ 3,213 $ 3,007 Selling, general and administrative expenses 459 455 911 906 Research, development and related expenses 131 127 262 252 Safety and Industrial operating income 859 738 1,635 1,437 Transportation and Electronics Cost of sales 1,176 1,110 2,271 2,176 Selling, general and administrative expenses 259 245 492 496 Research, development and related expenses 128 110 249 219 Transportation and Electronics operating income 503 479 902 869 Consumer Cost of sales 750 748 1,437 1,417 Selling, general and administrative expenses 212 223 408 427 Research, development and related expenses 33 31 64 63 Consumer operating income 252 268 469 487 Total reportable business segment operating income 1,614 1,485 3,006 2,793 Corporate Corporate-level (expense) income 1 22 35 72 Corporate special items: Net costs for significant litigation and PFAS exit (183) (347) (13) (421) Business acquisition-related costs (12) — (12) — (Loss) gain on business divestitures (336) (3) (343) (3) Manufactured PFAS products — (17) (126) (55) Transformation costs (100) — (166) — Total Corporate (630) (345) (625) (407) Total Company operating income 984 1,140 2,381 2,386 Other expense/(income), net (136) 217 383 78 Income before income taxes $ 1,120 $ 923 $ 1,998 $ 2,308 Three months ended June 30, Six months ended June 30, Depreciation and amortization (millions) 2026 2025 2026 2025 Safety and Industrial $ 146 $ 141 $ 290 $ 280 Transportation and Electronics 91 92 179 180 Consumer 43 36 83 75 Corporate 55 21 109 45 Total $ 335 $ 290 $ 661 $ 580 Capital expenditures (millions) Safety and Industrial $ 112 $ 77 $ 197 $ 155 Transportation and Electronics 77 104 135 182 Consumer 20 16 31 27 Corporate 14 11 85 80 Total $ 223 $ 208 $ 448 $ 444 41 Table of Contents Assets (millions) June 30, 2026 December 31, 2025 Business segment assets: Inventories Safety and Industrial $ 1,664 $ 1,636 Transportation and Electronics 1,080 1,068 Consumer 788 694 Total business segment assets 3,532 3,398 All other current assets 10,580 12,989 Total non-current assets 20,812 21,346 Total assets $ 34,924 $ 37,733 "Business segment assets" represent inventories, based on the extent of business segment information regularly provided to 3M's CODM.
Note 16, Business Segment Information: comparative sales and operating results · Filed 21/07/2026
Margins were also impacted by lower sales volumes, inflation impacts, investments in the business, higher restructuring costs, manufacturing and supply chain headwinds and China-related challenges partially offset by benefits from aggressive spending discipline, pricing and productivity actions.
Segment performance discussion: pricing and productivity partly offset operating headwinds · Filed 07/02/2024
Margins were also impacted by increased raw materials and logistics costs, manufacturing productivity headwinds which were further magnified by the shutdown of certain operations in Belgium and investments in auto electrification, partially offset by selling price actions, strong spending discipline and restructuring actions.
Segment performance discussion: selling-price actions and production cost pressures · Filed 07/02/2024
5 Table of Contents 3M Company and Subsidiaries Consolidated Statement of Cash Flows (Unaudited) Six months ended June 30, (Millions) 2026 2025 Cash flows from operating activities Net income including noncontrolling interest $ 1,597 $ 1,847 Adjustments to reconcile net income including noncontrolling interest to net cash provided by (used in) operating activities Depreciation and amortization 661 580 Company pension and postretirement contributions (73) (61) Company pension and postretirement expense 73 135 Stock-based compensation expense 121 129 Loss on business divestitures 343 3 Deferred income taxes 120 217 Changes in assets and liabilities Accounts receivable (414) (419) Inventories (132) (240) Accounts payable 421 182 Other — net (1,157) (3,406) Net cash provided by (used in) operating activities 1,560 (1,033) Cash flows from investing activities Purchases of property, plant and equipment (PP&E) (448) (444) Proceeds from sale of PP&E and other assets 14 21 Purchases of marketable securities and investments (294) (419) Proceeds from maturities and sale of marketable securities and investments 622 2,130 Proceeds from (payments for) sale of businesses, net of cash sold (326) 5 Other — net 9 (3) Net cash provided by (used in) investing activities (423) 1,290 Cash flows from financing activities Repayment of debt (maturities greater than 90 days) — (1,250) Proceeds from debt (maturities greater than 90 days) — 1,099 Purchases of treasury stock (2,993) (2,227) Proceeds from issuance of treasury stock pursuant to stock option and benefit plans 364 988 Dividends paid to shareholders (813) (786) Other — net (16) (15) Net cash provided by (used in) financing activities (3,458) (2,191) Effect of exchange rate changes on cash and cash equivalents (5) 46 Net increase (decrease) in cash and cash equivalents, including cash classified within assets held for sale (2,326) (1,888) Less: net increase (decrease) in cash classified within assets held for sale (46) — Net increase (decrease) in cash and cash equivalents (2,280) (1,888) Cash and cash equivalents at beginning of year 5,235 5,600 Cash and cash equivalents at end of period $ 2,955 $ 3,712 The accompanying Notes to Consolidated Financial Statements are an integral part of this statement.
Consolidated Statement of Cash Flows: first-half 2026 cash generation and deployment · Filed 21/07/2026
2025 Debt Activity: Debt cash flow activity includes $1.8 billion aggregate principal amount of debt maturities partially offset by proceeds from issuance of $1.1 billion in aggregate principal amount of debt in 2025.
MD&A, Financing Activities: actual 2025 debt maturities and issuance · Filed 03/02/2026
Plan (weighted 33.3%) •Individual performance multiplier (0% - 130%) •Strategic and Sustainability Scorecard modifier (±10% of target) Performance Shares •Motivate executives to focus on continuously improving performance in key financial metrics believed to drive long-term shareholder value •Retain executive talent •Performance metrics and goals approved by the Committee •Payouts based on cumulative performance results against preestablished goals for a three- year period •Maximum payout equal to 200% of the target number of performance shares •Cash-settled dividend equivalent rights that are payable only if the underlying shares are earned •Cumulative Earnings per Share (weighted 50%) •Cumulative Free Cash Flow (weighted 50%) •Relative total shareholder return modifier (±20%) Stock Options(2) •Motivate executives to build long-term shareholder value •Retain executive talent •Provide value only if stock price increases •Exercise price equal to the grant date closing price for a share of 3M common stock •Three-year ratable vesting schedule •Maximum term of 10 years •Vesting is based on continued service, while value of the options is based on stock price appreciation (100%) from the grant date Restricted Stock Units(2) •Motivate executives to build long-term shareholder value •Retain executive talent •Three-year “cliff” vesting schedule •Cash-settled dividend equivalent rights that are payable only if the underlying shares are earned •Vesting is based on continued service, while value of the RSUs fluctuates based on total shareholder return (100%) Fixed Pay Base Salary Annual Incentives Incentive-Based At-Risk Pay Long-Term Incentives (1)Percentages shown reflect the apportionment (or, in the case of the percentages shown for the Other NEOs, the average apportionment) of the components of target Total Direct Compensation that are expected to be recurring.
Executive compensation: performance-share metrics and equity award terms · Filed 25/03/2026
55 3M Company Executive compensation (2)For 2025, the Committee chose to deliver 50 percent of the target grant value of the annual long-term incentive awards granted to each Named Executive Officer in the form of performance shares.
Executive compensation: actual 2025 long-term incentive award composition · Filed 25/03/2026
In completing its assessment of potential 2025 adjustments, the Committee accepted management’s recommendation not to exclude the impact of new tariffs enacted in 2025.
Executive compensation: decision to retain tariff effects in performance calculations · Filed 25/03/2026
In January 2026, the Committee then reviewed and approved the exclusion of the following special items for purposes of the 2025 AIP and performance share award payout calculations: 2026 Proxy Statement 70 Executive compensation •Write-down and loss on sale related to divestiture of the precision grinding and finishing business and fused silica business; •Costs associated with 3M's transformation program, intended as a structural redesign of longer-term manufacturing, distribution, and business process services and locations; •Net costs for significant litigation related to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other environmental, and Combat Arms Earplugs matters; •Gains in the value of 3M’s remaining ownership in Solventum; and •PFAS manufacturing exit impacts.
Executive compensation: January 2026 approval of exclusions for 2025 payouts · Filed 25/03/2026
We prohibit our executive officers from hedging or pledging 3M common stock.
Compensation policies: executive hedging and pledging prohibition · Filed 25/03/2026
The Corporate Governance Guidelines provide, in part, that: •Independent directors comprise a substantial majority of the Board; •Directors are elected annually by a majority vote in uncontested director elections; •Only independent directors serve on the Audit, Compensation and Talent, Nominating and Governance, and Science, Technology & Sustainability Committees; •The committee chairs establish their respective agendas; •The Board and committees may retain their own advisors; •Independent directors have complete access to management and employees; •Independent directors meet in executive session without the CEO or other employees during each regular Board meeting; and •The Board and each committee regularly conduct a self-evaluation to determine whether it and its committees function effectively.
Corporate governance: independence, elections and committee safeguards · Filed 25/03/2026
James R. Fitterling, who has served on 3M’s Board since 2021, including as the Chair of the Compensation and Talent Committee of the Board, has been 3M’s Lead Independent Director since April 3, 2024.
Corporate governance: serving Lead Independent Director · Filed 25/03/2026
The Audit Committee has adopted procedures to receive, retain, and treat complaints received regarding accounting, internal accounting controls, or auditing matters, and to allow for the confidential and anonymous submission by employees or others of concerns regarding questionable accounting or auditing matters.
Corporate governance: adopted confidential complaint procedures · Filed 25/03/2026
3M completed its exit of PFAS manufacturing at the end of 2025 as discussed in Part I, Item 1A, “Risk Factors” of this document.
MD&A: completed PFAS manufacturing exit at year-end 2025 · Filed 03/02/2026
